PuSH - Publikationsserver des Helmholtz Zentrums München: HBV-infected HepG2hNTCP cells serve as a novel immunological tool to analyze the antiviral efficacy of CD8+ T cells in vitro.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Hoh, A.* ; Heeg, M.* ; Ni, Y.* ; Schuch, A.* ; Binder, B.* ; Hennecke, N.* ; Blum, H.E.* ; Nassal, M.* ; Protzer, U. ; Hofmann, M.* ; Urban, S.* ; Thimme, R.*

HBV-infected HepG2^hNTCP cells serve as a novel immunological tool to analyze the antiviral efficacy of CD8⁺ T cells in vitro.

J. Virol. 89, 7433-7438 (2015)

Postprint

DOI

PMC

	Open Access Green

Abstract
Metriken
Zusatzinfos

CD8(+) T cells are main effector lymphocytes in the control of hepatitis B virus (HBV) infection. However, limitations of model systems such as low infection rates restricted mechanistic studies of HBV-specific CD8(+) T cells. Here, we established a novel immunological cell culture model based on HBV-infected HepG2(hNTCP) cells that endogenously processed and presented viral antigens to HBV-specific CD8(+) T cells. This induced cytolytic and non-cytolytic CD8(+) T-cell effector functions and reduction of viral loads.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

4.439

1.200